Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, Agilent Post Strong Gains in BCW

Qiagen and Agilent both had strong stock gains during the past week, leading the BioCommerce Week Index of multi-platform molecular biology tool firms. Qiagen shares rose 10 percent, though the reason for the upward movement is not readily apparent. Agilent's shares climbed 9.78 percent, due largely to a report in the Wall Street Journal that the firm's semiconductor business could be sold as early as late this week for as much as $2.5 billion.

Overall, the Index gained 1.16 percent for the week, trailing the Dow Jones Industrial Average, which gained 1.4 percent, the Nasdaq, which rose 3.1 percent, and the Nasdaq Biotech Index, which gained a robust 5.1 percent for the week.

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(
July 12, 2005)
Last Price
(July 5, 2005)
% Change
Agilent
A
25.93
23.62
9.78
Applied Biosystems
ABI
20.26
20.31
-0.25
Beckman
BEC
64.05
64.96
-1.40
Bio-Rad
BIO
59.8
58.85
1.61
Bruker
BRKR
4.13
4.13
0.00
GE
GE
35.1
34.72
1.09
Harvard Bio
HBIO
3.28
3.18
3.14
Invitrogen
IVGN
83.88
84.9
-1.20
Molecular Devices
MDCC
20.75
21.8
-4.82
PerkinElmer
PKI
20.04
19.7
1.73
Qiagen
QGEN
13.15
11.95
10.04
Sigma
SIAL
57.49
55.99
2.68
Strategene
STGN
8.73
8.59
1.63
Thermo
TMO
27.98
26.7
4.68
Waters
WAT
38.9
38.49
1.07
Index Average
32.23
31.86
1.16
The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.